429 related articles for article (PubMed ID: 32237930)
1. How do EQ-5D-3L and EQ-5D-5L compare in a Swedish total hip replacement population?
Eneqvist T; Nemes S; Kärrholm J; Burström K; Rolfson O
Acta Orthop; 2020 Jun; 91(3):272-278. PubMed ID: 32237930
[TBL] [Abstract][Full Text] [Related]
2. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
3. The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty.
Greene ME; Rader KA; Garellick G; Malchau H; Freiberg AA; Rolfson O
Clin Orthop Relat Res; 2015 Nov; 473(11):3383-90. PubMed ID: 25488404
[TBL] [Abstract][Full Text] [Related]
4. Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement.
Conner-Spady BL; Marshall DA; Bohm E; Dunbar MJ; Loucks L; Al Khudairy A; Noseworthy TW
Qual Life Res; 2015 Jul; 24(7):1775-84. PubMed ID: 25555837
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the EQ-5D-3L and 5L versions in low back pain patients.
Garratt AM; Furunes H; Hellum C; Solberg T; Brox JI; Storheim K; Johnsen LG
Health Qual Life Outcomes; 2021 May; 19(1):155. PubMed ID: 34049574
[TBL] [Abstract][Full Text] [Related]
6. Responsiveness of the EQ-5D-3L and EQ-5D-5L in patients following total hip or knee replacement.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Johnson JA
Qual Life Res; 2019 Sep; 28(9):2409-2417. PubMed ID: 31089988
[TBL] [Abstract][Full Text] [Related]
7. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
Feng Y; Devlin N; Herdman M
Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
[TBL] [Abstract][Full Text] [Related]
8. Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds.
van Heusden A; Rivero-Arias O; Herdman M; Hiscock H; Devlin N; Dalziel K;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):129-145. PubMed ID: 38238604
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in patients with lower limb amputation - an assessment of the measurement properties of EQ-5D-3L and EQ-5D-5L using data from the Swedish Amputation and Prosthetics Registry.
Ernstsson O; Hagberg K; Janssen MF; Bonsel GJ; Korkmaz S; Zethraeus N; Heintz E
Disabil Rehabil; 2022 Dec; 44(26):8471-8479. PubMed ID: 34932426
[TBL] [Abstract][Full Text] [Related]
10. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
[TBL] [Abstract][Full Text] [Related]
11. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
[TBL] [Abstract][Full Text] [Related]
12. Concordance among Swedish, German, Danish, and UK EQ-5D-3L Value Sets: Analyses of Patient-Reported Outcomes in the Swedish Hip Arthroplasty Register.
Teni FS; Rolfson O; Berg J; Leidl R; Burström K
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575317
[No Abstract] [Full Text] [Related]
13. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
[TBL] [Abstract][Full Text] [Related]
14. Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China.
Jiang J; Hong Y; Zhang T; Yang Z; Lin T; Liang Z; Lu P; Liu L; Wang B; Xu Y; Luo N
Qual Life Res; 2021 Jul; 30(7):2045-2060. PubMed ID: 33821418
[TBL] [Abstract][Full Text] [Related]
15. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients.
Pickard AS; De Leon MC; Kohlmann T; Cella D; Rosenbloom S
Med Care; 2007 Mar; 45(3):259-63. PubMed ID: 17304084
[TBL] [Abstract][Full Text] [Related]
16. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea.
Kim SH; Kim HJ; Lee SI; Jo MW
Qual Life Res; 2012 Aug; 21(6):1065-73. PubMed ID: 21947656
[TBL] [Abstract][Full Text] [Related]
17. Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases.
Scalone L; Ciampichini R; Fagiuoli S; Gardini I; Fusco F; Gaeta L; Del Prete A; Cesana G; Mantovani LG
Qual Life Res; 2013 Sep; 22(7):1707-16. PubMed ID: 23192232
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the three-level and the five-level versions of the EQ-5D.
Christiansen ASJ; Møller MLS; Kronborg C; Haugan KJ; Køber L; Højberg S; Brandes A; Graff C; Diederichsen SZ; Nielsen JB; Krieger D; Holst AG; Svendsen JH
Eur J Health Econ; 2021 Jun; 22(4):621-628. PubMed ID: 33733344
[TBL] [Abstract][Full Text] [Related]
19. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.
Pattanaphesaj J; Thavorncharoensap M
Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017
[TBL] [Abstract][Full Text] [Related]
20. Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population.
Kangwanrattanakul K; Parmontree P
Qual Life Res; 2020 Dec; 29(12):3407-3417. PubMed ID: 32780315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
